Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Post-epidemic eosinophilia myalgia syndrome associated with L-Tryptophan


ABSTRACT: Eosinophilia–myalgia syndrome (EMS) is characterized by subacute onset of myalgias and peripheral eosinophilia, followed by chronic neuropathy and skin induration. The EMS epidemic in 1989 was linked to L-tryptophan consumption originating from a single source. Following the Food and Drug Administration (FDA) ban on the sale of L-tryptophan, the incidence of EMS declined rapidly. Moreover, no new cases have been published since the FDA ban was lifted in 2005. We report the clinical, histopathological and immunogenetic features of a new case of L-tryptophan-associated EMS along with evidence of activated transforming growth factor-ß and interleukin-4 signaling in the lesional skin. 6 samples were analyzed to include EMS patient and two replicates along with three normal controls

ORGANISM(S): Homo sapiens

SUBMITTER: Tammara Wood 

PROVIDER: E-GEOD-26934 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-01-28 | GSE26934 | GEO
| PRJNA136089 | ENA
2010-07-21 | GSE23015 | GEO
2020-12-04 | PXD020224 | Pride
2017-02-24 | E-MTAB-5542 | biostudies-arrayexpress
2023-12-23 | PXD048093 | Pride
2021-03-05 | GSE168214 | GEO
| PRJNA413005 | ENA
2020-10-18 | GSE142822 | GEO
2021-02-03 | GSE165969 | GEO